BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Aug 8, 2026; 7(2): 120311
Published online Aug 8, 2026. doi: 10.35712/aig.120311
Table 2 Prognostic vs predictive modeling in advanced hepatocellular carcinoma
Feature
Prognostic model
Predictive model
Core questionWhat is the patient’s outcome risk?Does the patient benefit more from treatment A vs B?
Treatment considerationIgnored or uniformCentral to model structure
Typical datasetSingle-treatment cohortMulti-treatment or counterfactual framework
Key bias riskOverfittingConfounding by indication
Statistical requirementDiscrimination and calibrationCausal inference methods (propensity modeling, counterfactual ML, uplift models)
Clinical utilityRisk stratificationTherapy selection guidance


Write to the Help Desk